Follow
Cameron Callaghan
Cameron Callaghan
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma
J Liu, B Boonkaew, J Arora, SH Mandava, MM Maddox, S Chava, ...
Journal of pharmaceutical sciences 104 (3), 1187-1196, 2015
522015
Optimizing advances in nanoparticle delivery for cancer immunotherapy
JM Caster, C Callaghan, SN Seyedin, K Henderson, B Sun, AZ Wang
Advanced drug delivery reviews 144, 3-15, 2019
452019
Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniques
CM Callaghan, Q Adams, RT Flynn, X Wu, W Xu, Y Kim
International Journal of Radiation Oncology* Biology* Physics 105 (1), 206-221, 2019
372019
Combination therapy with radiation and PARP inhibition enhances responsiveness to anti-PD-1 therapy in colorectal tumor models
SN Seyedin, MM Hasibuzzaman, V Pham, MS Petronek, C Callaghan, ...
International Journal of Radiation Oncology* Biology* Physics 108 (1), 81-92, 2020
362020
Brachytherapy future directions
JAM Cunha, R Flynn, C Bélanger, C Callaghan, Y Kim, X Jia, Z Chen, ...
Seminars in radiation oncology 30 (1), 94-106, 2020
352020
Nanotechnology combined therapy: tyrosine kinase‐bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a …
J Liu, C Abshire, C Carry, AB Sholl, SH Mandava, A Datta, M Ranjan, ...
BJU international 119 (2), 342-348, 2017
212017
Combined treatment of tyrosine kinase inhibitor–labeled gold nanorod encapsulated albumin with laser thermal ablation in a renal cell carcinoma model
C Callaghan, D Peralta, J Liu, SH Mandava, M Maddox, S Dash, MA Tarr, ...
Journal of pharmaceutical sciences 105 (1), 284-292, 2016
192016
Neoadjuvant radiotherapy-related wound morbidity in soft tissue sarcoma: perspectives for radioprotective agents
CM Callaghan, MM Hasibuzzaman, SN Rodman, JE Goetz, KA Mapuskar, ...
Cancers 12 (8), 2258, 2020
152020
The effect of concurrent stereotactic body radiation and anti-PD-1 therapy for recurrent metastatic sarcoma
CM Callaghan, SN Seyedin, IH Mohiuddin, KL Hawkes, MS Petronek, ...
Radiation research 194 (2), 124-132, 2020
122020
Outcomes comparison for microsurgical breast reconstruction in specialty surgery hospitals versus tertiary care facilities
R Vemula, MJ Bartow, M Freeman, C Callaghan, T Matatov, D Jansen, ...
Plastic and Reconstructive Surgery–Global Open 5 (10), e1514, 2017
92017
Nanotechnology applications in urology: a review
M Maddox, J Liu, SH Mandava, C Callaghan, V John, BR Lee
BJU international 114 (5), 653-660, 2014
92014
Assessment of gadobutrol safety in combination with ionizing radiation using a preclinical MRI-guided radiotherapy model
MS Petronek, EJ Steinbach, AL Kalen, ZJ Builta, CM Callaghan, DE Hyer, ...
Radiation research 195 (3), 230-234, 2021
72021
Low-dose-rate prostate brachytherapy: 4–8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival
CM Callaghan, L Wang, A Alluri, A Lauve, C Boyer, W Russell
Brachytherapy 16 (6), 1119-1128, 2017
42017
MP39-01 in vitro performance of sorafenib-loaded PLGA and liposome nanoparticles as a delivery system in the treatment of renal cell carcinoma
J Liu, B Boonkaew, SH Mandava, J Arora, M Maddox, S Chava, ...
The Journal of Urology 193 (4S), e454-e455, 2015
32015
Assessing Changes in Circulating Tumor Cells (CTCs) during Preoperative Chemoradiotherapy for Gastrointestinal Malignancies Using a Nanotechnology-Based CTC Capture System
SN Seyedin, CM Callaghan, M Poellmann, J Bu, AZ Wang, S Hong, ...
International journal of radiation oncology, biology, physics 105 (1), S113-S114, 2019
22019
Scientific Program of 33rd World Congress of Endourology & SWL Program Book
JK Shen, DN Tryon, KC Myklak, MM Alsyouf, BS Peplinski, C Conceicao, ...
Journal of Endourology 29, 1, 2015
22015
The Role of Destrin Wnt/β-Catenin Signaling Pathway in Rectal Cancer Oncogenesis
V Ho, CM Callaghan
International Journal of Radiation Oncology, Biology, Physics 117 (1), 211-213, 2023
12023
MP69-01 NANOTECHNOLOGY COMBINATION THERAPY: SORAFENIB BOUND GOLD NANORODS PRODUCES HIGHER TREATMENT RESPONSE WHEN COMBINED WITH LASER THERMAL ABLATION IN A RENAL CELL CARCINOMA …
C Callaghan, SH Mandava, D Peralta, M Bouljihad, S Dash, J Liu, ...
The Journal of Urology 193 (4S), e866-e867, 2015
12015
Differential distribution of the DNA-PKcs inhibitor peposertib selectively radiosensitizes patient-derived melanoma brain metastasis xenografts
J Ji, S Dragojevic, CM Callaghan, EJ Smith, S Talele, W Zhang, ...
Molecular Cancer Therapeutics, OF1-OF10, 2024
2024
Enhancing the therapeutic gain of proton radiotherapy in Locally Advanced Rectal Cancer (LARC) through manipulation of WSB1, ATM, and beta-Catenin/c-Myc pathway Ubiquitination
S Dragojevic, CM Callaghan
MOLECULAR CANCER THERAPEUTICS 22 (12), 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20